查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1474903

总体基因体学市场规模、份额、趋势分析报告：依产品、技术、工作流程、应用、区域、细分市场预测，2024-2030

Metagenomics Market Size, Share & Trends Analysis Report By Technology (Shotgun Sequencing, Whole Genome Sequencing), By Product, By Workflow, By Application, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 137 Pages | 商品交期: 2-10个工作天内

价格

总体基因体学市场成长与趋势：

Grand View Research, Inc. 的最新报告显示，到 2030 年，全球总体基因体学市场规模预计将达到 48.2 亿美元。

预计2024年至2030年市场将以13.52%的复合年增长率扩张。基因组学和蛋白​​质组学研究的增加、个人化药物的采用增加以及对生物製药的需求不断增加正在推动对测序仪的需求，从而推动行业增长。例如，2022 年 8 月，Illumina, Inc. 宣布计划透过开发解决方案中心来扩大其在巴西的基因组学业务。新设施的创建是临床基因组学需求不断增长和加速公司在拉丁美洲的足迹的结果。

据估计，各公司活性化的研发投资将对总体基因体学在许多应用中的使用产生重大影响。例如，2021年4月，安捷伦科技公司收购了Resolution Bioscience, Inc.，一家基于NGS的精准肿瘤学解决方案开发商。 Resolution Bioscience 的非侵入性液态切片平台与安捷伦基于组织的伴同性诊断技术的结合预计将扩大安捷伦在精准肿瘤学 NGS 技术领域的市场地位。

总体基因体学在环境应用中广泛采用的另一个因素是微生物直接参与生物地球化学循环。微生物对石油碳氢化合物等碳源的降解促使研究人员研究生质燃料生产的总体基因体学过程。此外，未培养的微生物中存在许多未被发现的生物分子，加速了总体基因体学在农业、食品安全、化学、工业和其他相关应用中的采用。

自 COVID-19 爆发以来，生命科学和生物技术行业的主要相关人员一直在寻求追踪、检测和治疗 COVID-19 的解决方案。总体基因体学分析在病毒检测和追踪中发挥重要作用。已经部署了各种序列监测平台和解决方案来有效诊断感染。例如，2021 年 5 月，牛津大学和Oracle宣布建立策略合作伙伴关係，开发强大的云端基础的基因组定序和分析平台，以降低冠状病毒感染的风险。

此外，政府为鼓励使用NGS平台进行学术研究而提供的资金将进一步增加总体基因体学工具的使用。例如，2021 年 2 月，加拿大政府投资 5,300 万美元实施多层方法来诊断 COVID-19。加拿大政府计划利用基因组序列测定和分析技术来实现预期结果。

总体基因体学成的资料品质也是增加分析成本的因素。资料品质很大程度取决于序列测定过程中的平均运行次数。高品质的分析是有代价的。然而，由于 RNA-Seq 等新技术的准确性和快速结果以及价格的下降，其采用正在迅速增加。据观察，定序成本每年增加5-10倍，运算能力每两年增加一倍。

总体基因体学市场报告亮点

  • 2023年，套件和试剂业务收益占有率最大，超过61.48%。套件和试剂专为特定应用而设计，例如土壤、水和生物样本分析。
  • 2023年，霰弹枪定序领域的收益占有率最大，为34.08%。霰弹枪定序透过将 DNA 随机分成小片段并对每个片段进行定序来对整个基因组进行定序。
  • 定序序细分市场在2023年以53.39%的收益占有率占据市场主导地位。这一成长归功于定序技术进步所实现的成本效益和准确性。
  • 2023年，环保领域以25.02%的收益占有率主导市场。元基因组研究在农业和环境保护中的作用正在迅速扩大，利用序列分析和基因筛检来了解特定环境中的微生物，代表了了解微生物生态系统的新方法。
  • 2023年总体基因体学市场由北美主导，收益占有率为40.26%。该地区的主导地位取决于主要企业的存在、研发资金的增加以及测序技术的进步。
  • 预计亚太地区在预测期内将以最快的复合年增长率成长。这是由印度和中国在多种应用中采用总体基因体学的重大进展所推动的。

目录

第一章总体基因体学市场：调查方法与范围

第二章总体基因体学市场：执行摘要

  • 市场概述
  • 段简介
  • 竞争格局概览

第三章总体基因体学市场：变数、趋势、范围

  • 市场体系展望
  • 市场趋势及展望
  • 市场动态
  • 市场限制因素分析
  • 营商环境分析
  • COVID-19 影响分析

第四章总体基因体学市场：产品业务分析

  • 细分仪表板
  • 全球总体基因体学市场：产品变异分析
  • 2018-2030年全球总体基因体学市场规模与趋势分析（依产品）

第五章总体基因体学市场：技术的商业分析

  • 细分仪表板
  • 全球总体基因体学市场：技术波动分析
  • 2018-2030 年全球总体基因体学市场规模与趋势分析（按技术）

第六章总体基因体学市场：工作流程的商业分析

  • 细分仪表板
  • 全球总体基因体学市场：工作流程变化分析
  • 2018-2030 年全球总体基因体学市场规模与趋势分析（依工作流程）

第七章总体基因体学市场：应用的商业分析

  • 细分仪表板
  • 全球总体基因体学市场：应用变异分析
  • 2018-2030 年全球总体基因体学市场规模与趋势分析（按应用）

第八章区域业务分析

  • 区域仪表板
  • 2018-2030 年市场规模与预测/趋势分析
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 西班牙
    • 法国
    • 义大利
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 泰国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章 竞争格局

  • 参与企业
  • 策略规划
  • 2023 年企业市场分析
  • 参与企业概况
    • Bio-Rad Laboratories, Inc.
    • Illumina, Inc.
    • PerkinElmer, Inc
    • Thermo Fisher Scientific, Inc
    • Novogene Co., Ltd.
    • Promega Corporation
    • QIAGEN
    • Takara Bio, Inc.
    • Oxford Nanopore Technologies plc.
    • F. Hoffmann-La Roche Ltd.
Product Code: GVR-2-68038-452-9

Metagenomics Market Growth & Trends:

The global metagenomics market size is expected to reach USD 4.82 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.52% from 2024 to 2030. The increasing research in genomics and proteomics, the rising adoption of personalized medicines, and escalating requirement for biologic products are driving the demand for sequencing, fueling the growth of the industry. For instance, in August 2022, Illumina, Inc. announced its plans to expand genomics operations in Brazil by developing a solution center. The establishment of the new facility is the result of rising demand for clinical genomics and accelerating the company's footprint in Latin America.

A boost in R&D investments by the players is estimated to have a considerable impact on the usage of metagenomics in numerous applications. For instance, in April 2021, Agilent Technologies, Inc. acquired Resolution Bioscience, Inc., an NGS-based precision oncology solution developing company. The combination of Resolution Bioscience's noninvasive liquid biopsy platform with Agilent's tissue-based companion diagnostics is anticipated to expand Agilent's market position in NGS technologies for precision oncology.

Another factor contributing to the high adoption of metagenomics for environmental use is the direct involvement of microorganisms in the biogeochemical cycle. The degradation of carbon sources such as petroleum hydrocarbons by microbes has encouraged researchers to study metagenomics processes for the production of biofuels. In addition, the presence of a large number of undiscovered biomolecules in non-cultured microorganisms accelerated the adoption of metagenomics in agriculture, food safety, chemical, industrial, and other related applications.

Since the outbreak of COVID-19, key stakeholders in the life sciences and biotechnology industry are seeking solutions for COVID-19 tracking, detection, and treatment. Metagenomics analysis plays a crucial role in the detection and tracing of the virus. Various sequencing surveillance platforms and solutions are being deployed for effective diagnosis of infection. For instance, in May 2021, Oxford University and Oracle announced a strategic partnership to develop robust cloud-based genomic sequencing and analysis platform to mitigate the risk of coronavirus infection.

Moreover, funds provided by the government for promoting research in academic institutes, which use NGS platforms, further increase the usage of metagenomics tools. For instance, in February 2021, the Canadian government invested USD 53 million to implement a multilayered approach for the diagnosis of COVID-19. The Canadian government will utilize genome sequencing and analysis technologies to achieve desired outcomes.

The quality of data generated through metagenomics is another factor that increases the cost of analysis. The quality of data is highly dependent on the average number of times the bases are run during the sequencing process. The high-quality analysis is expensive. However, the adoption of emerging novel techniques, such as RNA-Seq, is rapidly increasing owing to accuracy and rapid results along with a decline in prices. It is observed that the cost of sequencing falls 5 to 10 times every year and the value of computing power doubles every two years.

Metagenomics Market Report Highlights:

  • The kits & reagents segment held the largest revenue share of over 61.48% in 2023. Kits & reagents are designed for specific applications, such as soil, water, and biological sample analysis.
  • The shotgun sequencing segment accounted for the largest revenue share of 34.08% in 2023. Shotgun sequencing sequences entire genomes by randomly breaking up DNA into small fragments and then sequencing each fragment.
  • The sequencing segment dominated the market with revenue share of 53.39% in 2023. The increase can be attributed to the cost-effectiveness and accuracy achieved through technological advancements in sequencing.
  • In 2023, the environmental segment dominated the market with a revenue share of 25.02%. The role of metagenomics research is swiftly expanding in agriculture and environmental protection, employing sequencing analysis or gene screening to comprehend microorganisms within a specific environment, marking a novel approach to understanding microbial ecosystems.
  • North America dominated the metagenomics market in 2023 with a revenue share of 40.26%. The region's dominance is determined through the presence of key companies, augmented R&D funding, and advancements in sequencing technology.
  • Asia Pacific is expected to grow at the fastest CAGR during the forecast period. This is driven by substantial advancements in metagenomics adoption across diverse applications in India and China.

Table of Contents

Chapter 1. Metagenomics Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Information analysis
    • 1.2.2. Market formulation & data visualization
    • 1.2.3. Data validation & publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Metagenomics Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Metagenomics Market: Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Declining expenses of sequencing
    • 3.3.2. Developments in biotechnology & bioinformatics techniques
    • 3.3.3. Rising interest in microbial screening for different investigations
    • 3.3.4. Emergence of new fields in genomics that complement metagenomics
  • 3.4. Market Restraint Analysis
    • 3.4.1. Limited accessibility to computation and different analytic tools
    • 3.4.2. High overall cost of metagenomics
  • 3.5. Business Environment Analysis
    • 3.5.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.5.2. Porter's Five Forces Analysis
  • 3.6. COVID - 19 Impact Analysis

Chapter 4. Metagenomics Market: Product Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Metagenomics Market Product Movement Analysis
  • 4.3. Global Metagenomics Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
    • 4.3.1. Kits and Reagents
      • 4.3.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 4.3.2. Sequencing & Data Analytics Services
      • 4.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 4.3.3. Software
      • 4.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 5. Metagenomics Market: Technology Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Metagenomics Market Technology Movement Analysis
  • 5.3. Global Metagenomics Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
    • 5.3.1. Shotgun Sequencing
      • 5.3.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.2. 16S Sequencing
      • 5.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.3. Whole Genome Sequencing
      • 5.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.4. Others
      • 5.3.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 6. Metagenomics Market: Workflow Business Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Metagenomics Market Workflow Movement Analysis
  • 6.3. Global Metagenomics Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
    • 6.3.1. Pre-sequencing
      • 6.3.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.3.2. Sequencing
      • 6.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.3.3. Data Analysis
      • 6.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 7. Metagenomics Market: Application Business Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Metagenomics Market Application Movement Analysis
  • 7.3. Global Metagenomics Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
    • 7.3.1. Environmental
      • 7.3.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 7.3.2. Clinical Diagnostics
      • 7.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 7.3.3. Drug Discovery
      • 7.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 7.3.4. Biotechnology
      • 7.3.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 7.3.5. Food & nutrition
      • 7.3.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 7.3.6. Others
      • 7.3.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Regional Dashboard
  • 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 8.3. North America
    • 8.3.1. North America Metagenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. U.S. Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Canada Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Metagenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. UK Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Germany Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.4.4. Spain
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Spain Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.4.5. France
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. France Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.4.6. Italy
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Italy Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Denmark Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Sweden Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Norway Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Metagenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. JAPAN
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Japan Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. China Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. India Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. South Korea Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Thailand Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.5.7. Australia
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Australia Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Metagenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Brazil Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.6.3. Mexico
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Mexico Metagenomics Market, 2018 - 2030 (USD Million)
    • 8.6.4. Argentina
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Argentina Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Metagenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. South Africa Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Saudi Arabia Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. UAE Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Kuwait Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2023
  • 9.4. Participant's Overview
    • 9.4.1. Bio-Rad Laboratories, Inc.
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Illumina, Inc.
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. PerkinElmer, Inc
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Thermo Fisher Scientific, Inc
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Novogene Co., Ltd.
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Promega Corporation
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. QIAGEN
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Takara Bio, Inc.
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Oxford Nanopore Technologies plc.
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. F. Hoffmann-La Roche Ltd.
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 4 Global Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 5 Global Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 6 Global Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 7 Global Sexual Health Supplements Market, By Region, 2018 - 2030 (USD Million)
  • Table 8 North America Metagenomics Market, Region, 2018 - 2030 (USD Million)
  • Table 9 North America Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 10 North America Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 11 North America Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 12 North America Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 13 U.S. Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 14 U.S. Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 15 U.S. Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 16 U.S. Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 17 Canada Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 18 Canada Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 19 Canada Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 20 Canada Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 21 Europe Metagenomics Market, Region, 2018 - 2030 (USD Million)
  • Table 22 Europe Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 23 Europe Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 24 Europe Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 25 Europe Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 26 UK Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 27 UK Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 28 UK Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 29 UK Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 30 Germany Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 31 Germany Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 32 Germany Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 33 Germany Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 34 France Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 35 France Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 36 France Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 37 France Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 38 Italy Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 39 Italy Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 40 Italy Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 41 Italy Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 42 Spain Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 43 Spain Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 44 Spain Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 45 Spain Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 46 Sweden Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 47 Sweden Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 48 Sweden Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 49 Sweden Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 50 Norway Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 51 Norway Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 52 Norway Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 53 Norway Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 54 Denmark Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 55 Denmark Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 56 Denmark Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 57 Denmark Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Metagenomics Market, Region, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 63 Japan Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 64 Japan Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 65 Japan Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 66 Japan Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 67 China Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 68 China Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 69 China Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 70 China Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 71 India Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 72 India Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 73 India Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 74 India Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 75 Australia Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 76 Australia Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 77 Australia Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 78 Australia Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 79 South Korea Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 80 South Korea Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 81 South Korea Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 82 South Korea Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 83 Thailand Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 84 Thailand Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 85 Thailand Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 86 Thailand Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 87 Latin America Metagenomics Market, Region, 2018 - 2030 (USD Million)
  • Table 88 Latin America Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 89 Latin America Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 90 Latin America Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 91 Latin America Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 92 Brazil Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 93 Brazil Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 94 Brazil Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 95 Brazil Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 96 Mexico Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 97 Mexico Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 98 Mexico Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 99 Mexico Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 100 Argentina Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 101 Argentina Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 102 Argentina Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 103 Argentina Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 104 MEA Metagenomics Market, Region, 2018 - 2030 (USD Million)
  • Table 105 MEA Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 106 MEA Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 107 MEA Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 108 MEA Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 109 South Africa Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 110 South Africa Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 111 South Africa Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 112 South Africa Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 117 UAE Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 118 UAE Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 119 UAE Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 120 UAE Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Metagenomics Market, By Application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Metagenomics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Parent market outlook
  • Fig. 13 Sexual health supplements market driver analysis
  • Fig. 14 Metagenomics market restraint analysis
  • Fig. 15 Metagenomics market: Porter's analysis
  • Fig. 16 Metagenomics market: PESTEL analysis
  • Fig. 17 Metagenomics market: Technology outlook and key takeaways
  • Fig. 18 Metagenomics market: Technology market share analysis, 2023 - 2030
  • Fig. 19 Global metagenomics by shotgun sequencing market, 2018 - 2030 (USD Million)
  • Fig. 20 Global metagenomics by 16S sequencing market, 2018 - 2030 (USD Million)
  • Fig. 21 Global metagenomics by whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 22 Global metagenomics by others market, 2018 - 2030 (USD Million)
  • Fig. 23 Metagenomics market: Product outlook and key takeaways
  • Fig. 24 Metagenomics market: Product market share analysis, 2023 - 2030
  • Fig. 25 Global metagenomics by kits & reagents market, 2018 - 2030 (USD Million)
  • Fig. 26 Global metagenomics by sequencing & data analytics services market, 2018 - 2030 (USD Million)
  • Fig. 27 Global metagenomics by software market, 2018 - 2030 (USD Million)
  • Fig. 28 Metagenomics market: Application outlook and key takeaways
  • Fig. 29 Metagenomics market: Application market share analysis, 2023 - 2030
  • Fig. 30 Global metagenomics by environmental market, 2018 - 2030 (USD Million)
  • Fig. 31 Global metagenomics by clinical diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 32 Global metagenomics by drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 33 Global metagenomics by biotechnology market, 2018 - 2030 (USD Million)
  • Fig. 34 Global metagenomics by food & nutrition market, 2018 - 2030 (USD Million)
  • Fig. 35 Global metagenomics by others market, 2018 - 2030 (USD Million)
  • Fig. 36 Metagenomics market: Workflow outlook and key takeaways
  • Fig. 37 Metagenomics market: Workflow market share analysis, 2023 - 2030
  • Fig. 38 Global metagenomics by pre-sequencing market, 2018 - 2030 (USD Million)
  • Fig. 39 Global metagenomics by sequencing market, 2018 - 2030 (USD Million)
  • Fig. 40 Global metagenomics by data analysis market, 2018 - 2030 (USD Million)
  • Fig. 41 Regional marketplace: Key takeaways
  • Fig. 42 North America metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 U.S. key country dynamics
  • Fig. 44 U.S. metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Canada key country dynamics
  • Fig. 46 Canada metagenomics market, 2018 - 2030 (USD Million)
  • Fig. 47 Europe metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 UK key country dynamics
  • Fig. 49 UK metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Germany key country dynamics
  • Fig. 51 Germany metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 France key country dynamics
  • Fig. 53 France metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Italy key country dynamics
  • Fig. 55 Italy metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Spain key country dynamics
  • Fig. 57 Spain metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Denmark key country dynamics
  • Fig. 59 Denmark metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Sweden key country dynamics
  • Fig. 61 Sweden metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Norway key country dynamics
  • Fig. 63 Norway metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Asia-Pacific metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Japan key country dynamics
  • Fig. 66 Japan metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 China key country dynamics
  • Fig. 68 China metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 India key country dynamics
  • Fig. 70 India metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Australia key country dynamics
  • Fig. 72 Australia metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Thailand key country dynamics
  • Fig. 74 Thailand metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 South Korea key country dynamics
  • Fig. 76 South Korea metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Latin America metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Brazil key country dynamics
  • Fig. 79 Brazil metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Mexico key country dynamics
  • Fig. 81 Mexico metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Argentina key country dynamics
  • Fig. 83 Argentina metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 MEA metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 South Africa key country dynamics
  • Fig. 86 South Africa metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 Saudi Arabia key country dynamics
  • Fig. 88 Saudi Arabia metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 UAE key country dynamics
  • Fig. 90 UAE metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 91 Kuwait key country dynamics
  • Fig. 92 Kuwait metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 93 Key company categorization
  • Fig. 94 Company market positioning
  • Fig. 95 Market participant categorization
  • Fig. 96 Strategy framework